{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:58:49Z","timestamp":1793249929692,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:00:00Z","timestamp":1764979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:00:00Z","timestamp":1764979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences","doi-asserted-by":"crossref","award":["97-01-87-37998"],"award-info":[{"award-number":["97-01-87-37998"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Biotechnology Development Council of the Islamic Republic of Iran","award":["970401"],"award-info":[{"award-number":["970401"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virus Genes"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s11262-025-02206-7","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T07:35:38Z","timestamp":1765006538000},"page":"67-79","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cell line engineering for enhanced measles virus production with sphingosine kinase 1 gene overexpression"],"prefix":"10.1007","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4089-3387","authenticated-orcid":false,"given":"Malihe","family":"Rastegarpanah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7899-156X","authenticated-orcid":false,"given":"Babak","family":"Negahdari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6993-6956","authenticated-orcid":false,"given":"Yazdan","family":"Asgari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5370-3111","authenticated-orcid":false,"given":"Mohammadali","family":"Mazloomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7165-9043","authenticated-orcid":false,"given":"Kayhan","family":"Azadmanesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,6]]},"reference":[{"issue":"4","key":"2206_CR1","doi-asserted-by":"publisher","first-page":"e214708","DOI":"10.1001\/jamanetworkopen.2021.4708","volume":"4","author":"L Rahib","year":"2021","unstructured":"Rahib L, Wehner MR, Matrisian LM, Nead KT (2021) Estimated projection of US cancer incidence and death to 2040. JAMA Netw Open 4(4):e214708\u2013e214708. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.4708","journal-title":"JAMA Netw Open"},{"issue":"3","key":"2206_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2206_CR3","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s12935-024-03424-z","volume":"24","author":"Z Yan","year":"2024","unstructured":"Yan Z, Zhang Z, Chen Y, Xu J, Wang J, Wang Z (2024) Enhancing cancer therapy: the integration of oncolytic virus therapy with diverse treatments. Cancer Cell Int 24(1):242. https:\/\/doi.org\/10.1186\/s12935-024-03424-z","journal-title":"Cancer Cell Int"},{"key":"2206_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cytogfr.2020.07.005","volume":"56","author":"MF Leber","year":"2020","unstructured":"Leber MF et al (2020) Engineering and combining oncolytic measles virus for cancer therapy. Cytokine Growth Factor Rev 56:39\u201348. https:\/\/doi.org\/10.1016\/j.cytogfr.2020.07.005","journal-title":"Cytokine Growth Factor Rev"},{"issue":"2","key":"2206_CR5","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3181\/00379727-86-21073","volume":"86","author":"JF Enders","year":"1954","unstructured":"Enders JF, Peebles TC (1954) Propagation in tissue cultures of cytopathogenic agents from patients with measles. Proc Soc Exp Biol Med 86(2):277\u2013286. https:\/\/doi.org\/10.3181\/00379727-86-21073","journal-title":"Proc Soc Exp Biol Med"},{"issue":"4","key":"2206_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.9734\/ijpr\/2023\/v12i4231","volume":"12","author":"R Nwalozie","year":"2023","unstructured":"Nwalozie R, Uzoechi M, Esiere RK, Nnokam BA (2023) Biology of measles virus: epidemiology and clinical manifestations. Int J Pathog Res 12(4):1\u201310. https:\/\/doi.org\/10.9734\/ijpr\/2023\/v12i4231","journal-title":"Int J Pathog Res"},{"key":"2206_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/v8090250","author":"L-T Lin","year":"2016","unstructured":"Lin L-T, Richardson CD (2016) The host cell receptors for measles virus and their interaction with the viral hemagglutinin (H) protein. Viruses. https:\/\/doi.org\/10.3390\/v8090250","journal-title":"Viruses"},{"key":"2206_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/antib9040059","author":"M Elvington","year":"2020","unstructured":"Elvington M, Liszewski MK, Atkinson JP (2020) CD46 and oncologic interactions: friendly fire against cancer. Antibodies. https:\/\/doi.org\/10.3390\/antib9040059","journal-title":"Antibodies"},{"issue":"2","key":"2206_CR9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2174\/1568009617666170222125035","volume":"18","author":"P Msaouel","year":"2018","unstructured":"Msaouel P et al (2018) Clinical trials with oncolytic measles virus: current status and future prospects. Curr Cancer Drug Targets 18(2):177\u2013187. https:\/\/doi.org\/10.2174\/1568009617666170222125035","journal-title":"Curr Cancer Drug Targets"},{"issue":"2","key":"2206_CR10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3844\/ajbbsp.2012.81.98","volume":"8","author":"K Weiss","year":"2012","unstructured":"Weiss K, Salzig D, M\u00fchlebach MD, Cichutek K, P\u00f6rtner R, Czermak P (2012) Key parameters of measles virus production for oncolytic virotherapy. Am J Biochem Biotechnol 8(2):81\u201398. https:\/\/doi.org\/10.3844\/ajbbsp.2012.81.98","journal-title":"Am J Biochem Biotechnol"},{"issue":"7","key":"2206_CR11","doi-asserted-by":"publisher","first-page":"549","DOI":"10.2217\/fvl-2016-0006","volume":"11","author":"MA Zahoor","year":"2016","unstructured":"Zahoor MA, Khurshid M, Qureshi R, Naz A, Shahid M (2016) Cell culture-based viral vaccines: current status and future prospects. Future Virol 11(7):549\u2013562. https:\/\/doi.org\/10.2217\/fvl-2016-0006","journal-title":"Future Virol"},{"key":"2206_CR12","doi-asserted-by":"publisher","unstructured":"K. K. Langfield, H. J. Walker, L. C. Gregory, and M. J. Federspiel, \u2018Manufacture of Measles Viruses\u2019, 2011, pp. 345\u2013366. https:\/\/doi.org\/10.1007\/978-1-61779-095-9_14.","DOI":"10.1007\/978-1-61779-095-9_14"},{"issue":"3","key":"2206_CR13","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1007\/s00253-011-3574-y","volume":"93","author":"K Trabelsi","year":"2012","unstructured":"Trabelsi K, Majoul S, Rourou S, Kallel H (2012) Development of a measles vaccine production process in MRC-5 cells grown on Cytodex1 microcarriers and in a stirred bioreactor. Appl Microbiol Biotechnol 93(3):1031\u20131040. https:\/\/doi.org\/10.1007\/s00253-011-3574-y","journal-title":"Appl Microbiol Biotechnol"},{"issue":"5","key":"2206_CR14","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/bit.26538","volume":"115","author":"TA Grein","year":"2018","unstructured":"Grein TA, Loewe D, Dieken H, Salzig D, Weidner T, Czermak P (2018) High titer oncolytic measles virus production process by integration of dielectric spectroscopy as online monitoring system. Biotechnol Bioeng 115(5):1186\u20131194. https:\/\/doi.org\/10.1002\/bit.26538","journal-title":"Biotechnol Bioeng"},{"issue":"9","key":"2206_CR15","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.vaccine.2022.01.004","volume":"40","author":"P Steppert","year":"2022","unstructured":"Steppert P et al (2022) A scalable, integrated downstream process for production of a recombinant measles virus-vectored vaccine. Vaccine 40(9):1323\u20131333. https:\/\/doi.org\/10.1016\/j.vaccine.2022.01.004","journal-title":"Vaccine"},{"key":"2206_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.virol.2013.11.039","volume":"450\u2013451","author":"M Vijayan","year":"2014","unstructured":"Vijayan M, Seo Y-J, Pritzl CJ, Squires SA, Alexander S, Hahm B (2014) Sphingosine kinase 1 regulates measles virus replication. Virology 450\u2013451:55\u201363. https:\/\/doi.org\/10.1016\/j.virol.2013.11.039","journal-title":"Virology"},{"key":"2206_CR17","doi-asserted-by":"publisher","unstructured":"L.-N. Smajovi\u0107, F. E. Oflaz, and A. Arslan, \u2018A Study of the CaCl2 Induced E. Coli DH5-Alpha Transformation by Heat Shock Accompanied by Vibration\u2019, 2021, pp. 557\u2013564. https:\/\/doi.org\/10.1007\/978-3-030-73909-6_65.","DOI":"10.1007\/978-3-030-73909-6_65"},{"key":"2206_CR18","unstructured":"M. R. Green and J. Sambrook, \u2018Molecular cloning\u2019, A Laboratory Manual 4th, vol. 448, 2012."},{"key":"2206_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2021.114348","volume":"299","author":"H Schulz","year":"2022","unstructured":"Schulz H, Hiebert J, Frost J, McLachlan E, Severini A (2022) Optimisation of methodology for whole genome sequencing of Measles Virus directly from patient specimens. J Virol Methods 299:114348. https:\/\/doi.org\/10.1016\/j.jviromet.2021.114348","journal-title":"J Virol Methods"},{"key":"2206_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2021.114318","volume":"299","author":"D Hochdorfer","year":"2022","unstructured":"Hochdorfer D, Businger R, Hotter D, Seifried C, Solzin J (2022) Automated, label-free TCID50 assay to determine the infectious titer of virus-based therapeutics. J Virol Methods 299:114318","journal-title":"J Virol Methods"},{"issue":"3","key":"2206_CR21","doi-asserted-by":"publisher","first-page":"181","DOI":"10.4155\/bio-2020-0267","volume":"13","author":"SM Manohar","year":"2021","unstructured":"Manohar SM, Shah P, Nair A (2021) Flow cytometry: principles, applications and recent advances. Bioanalysis 13(3):181\u2013198","journal-title":"Bioanalysis"},{"key":"2206_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/bit.28980","author":"EA Green","year":"2025","unstructured":"Green EA et al (2025) Development of an HEK293 suspension cell culture medium, transient transfection optimization workflow, and analytics for batch rAAV manufacturing. Biotechnol Bioeng. https:\/\/doi.org\/10.1002\/bit.28980","journal-title":"Biotechnol Bioeng"},{"issue":"7","key":"2206_CR23","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/ijc.35278","volume":"156","author":"AM Filho","year":"2025","unstructured":"Filho AM et al (2025) The <scp>GLOBOCAN<\/scp> 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide. Int J Cancer 156(7):1336\u20131346. https:\/\/doi.org\/10.1002\/ijc.35278","journal-title":"Int J Cancer"},{"key":"2206_CR24","doi-asserted-by":"publisher","unstructured":"K. Weiss, D. Salzig, M. D. M\u00fchlebach, K. Cichutek, R. P&ouml;rtner, and P. Czermak, \u2018KEY PARAMETERS OF MEASLES VIRUS PRODUCTION FOR ONCOLYTIC VIROTHERAPY\u2019, Am J Biochem Biotechnol, vol. 8, no. 2 SE-Research Article, 2012, https:\/\/doi.org\/10.3844\/ajbbsp.2012.81.98.","DOI":"10.3844\/ajbbsp.2012.81.98"},{"issue":"5","key":"2206_CR25","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1021\/acsinfecdis.2c00416","volume":"9","author":"CM Stewart","year":"2023","unstructured":"Stewart CM et al (2023) Sphingosine kinases promote Ebola virus infection and can be targeted to inhibit filoviruses, coronaviruses, and arenaviruses using late endocytic trafficking to enter cells. ACS Infect Dis 9(5):1064\u20131077. https:\/\/doi.org\/10.1021\/acsinfecdis.2c00416","journal-title":"ACS Infect Dis"},{"issue":"10","key":"2206_CR26","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.4049\/jimmunol.2400088","volume":"213","author":"L Zhang","year":"2024","unstructured":"Zhang L et al (2024) Hepatitis B virus increases SphK1\u2013S1P synthesis by promoting the availability of the transcription factor USF1. J Immunol 213(10):1499\u20131507. https:\/\/doi.org\/10.4049\/jimmunol.2400088","journal-title":"J Immunol"},{"issue":"20","key":"2206_CR27","doi-asserted-by":"publisher","first-page":"13648","DOI":"10.1074\/jbc.M807498200","volume":"284","author":"D Yamane","year":"2009","unstructured":"Yamane D et al (2009) Inhibition of sphingosine kinase by bovine viral diarrhea virus NS3 is crucial for efficient viral replication and cytopathogenesis. J Biol Chem 284(20):13648\u201313659. https:\/\/doi.org\/10.1074\/jbc.M807498200","journal-title":"J Biol Chem"},{"issue":"38","key":"2206_CR28","doi-asserted-by":"publisher","first-page":"26148","DOI":"10.1074\/jbc.M710181200","volume":"283","author":"NJ Machesky","year":"2008","unstructured":"Machesky NJ et al (2008) Human cytomegalovirus regulates bioactive sphingolipids. J Biol Chem 283(38):26148\u201326160. https:\/\/doi.org\/10.1074\/jbc.M710181200","journal-title":"J Biol Chem"},{"issue":"8","key":"2206_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075005","volume":"8","author":"Y-J Seo","year":"2013","unstructured":"Seo Y-J et al (2013) Sphingosine kinase 1 serves as a pro-viral factor by regulating viral RNA synthesis and nuclear export of viral ribonucleoprotein complex upon influenza virus infection. PLoS ONE 8(8):e75005. https:\/\/doi.org\/10.1371\/journal.pone.0075005","journal-title":"PLoS ONE"},{"issue":"3","key":"2206_CR30","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00430-010-0152-3","volume":"199","author":"E Avota","year":"2010","unstructured":"Avota E, Gassert E, Schneider-Schaulies S (2010) Measles virus-induced immunosuppression: from effectors to mechanisms. Med Microbiol Immunol 199(3):227\u2013237. https:\/\/doi.org\/10.1007\/s00430-010-0152-3","journal-title":"Med Microbiol Immunol"},{"issue":"12","key":"2206_CR31","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1016\/j.bbamem.2006.06.015","volume":"1758","author":"C Donati","year":"2006","unstructured":"Donati C, Bruni P (2006) Sphingosine 1-phosphate regulates cytoskeleton dynamics: implications in its biological response. Biochimica et Biophysica Acta (BBA) - Biomembranes 1758(12):2037\u20132048. https:\/\/doi.org\/10.1016\/j.bbamem.2006.06.015","journal-title":"Biochimica et Biophysica Acta (BBA) - Biomembranes"},{"issue":"13","key":"2206_CR32","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.3390\/cells11132058","volume":"11","author":"G\u00c1 Bravo","year":"2022","unstructured":"Bravo G\u00c1, Cede\u00f1o RR, Casadevall MP, Rami\u00f3-Torrent\u00e0 L (2022) Sphingosine-1-phosphate (S1P) and S1P signaling pathway modulators, from current insights to future perspectives. Cells 11(13):2058","journal-title":"Cells"},{"issue":"2","key":"2206_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/v15020260","volume":"15","author":"S Suwanmanee","year":"2023","unstructured":"Suwanmanee S, Ghimire S, Edwards J, Griffin DE (2023) Infection of pro- and anti-inflammatory macrophages by wild type and vaccine strains of measles virus: NLRP3 inflammasome activation independent of virus production. Viruses 15(2):260. https:\/\/doi.org\/10.3390\/v15020260","journal-title":"Viruses"},{"issue":"4","key":"2206_CR34","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1285992","volume":"6","author":"R Veinalde","year":"2017","unstructured":"Veinalde R et al (2017) Oncolytic measles virus encoding interleukin-12 mediates potent antitumor effects through T cell activation. Oncoimmunology 6(4):e1285992. https:\/\/doi.org\/10.1080\/2162402X.2017.1285992","journal-title":"Oncoimmunology"},{"key":"2206_CR35","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/J.CECA.2019.03.005","volume":"80","author":"J Li","year":"2019","unstructured":"Li J, Zhang X, Song X, Liu R, Zhang J, Li Z (2019) The structure of TRPC ion channels. Cell Calcium 80:25\u201328. https:\/\/doi.org\/10.1016\/J.CECA.2019.03.005","journal-title":"Cell Calcium"},{"issue":"9","key":"2206_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012569","volume":"20","author":"L Amurri","year":"2024","unstructured":"Amurri L et al (2024) Multifaceted activation of STING axis upon Nipah and measles virus-induced syncytia formation. PLoS Pathog 20(9):e1012569. https:\/\/doi.org\/10.1371\/journal.ppat.1012569","journal-title":"PLoS Pathog"},{"key":"2206_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2019.00218","author":"A Grafen","year":"2019","unstructured":"Grafen A, Schumacher F, Chithelen J, Kleuser B, Beyersdorf N, Schneider-Schaulies J (2019) Use of acid ceramidase and sphingosine kinase inhibitors as antiviral compounds against measles virus infection of lymphocytes in vitro. Front Cell Dev Biol. https:\/\/doi.org\/10.3389\/fcell.2019.00218","journal-title":"Front Cell Dev Biol"},{"key":"2206_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.856143","author":"J Chithelen","year":"2022","unstructured":"Chithelen J, Franke H, L\u00e4nder N, Grafen A, Schneider-Schaulies J (2022) The sphingolipid inhibitors Ceranib-2 and SKI-II reduce measles virus replication in primary human lymphocytes: effects on mTORC1 downstream signaling. Front Physiol. https:\/\/doi.org\/10.3389\/fphys.2022.856143","journal-title":"Front Physiol"},{"key":"2206_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2023.101251","volume":"92","author":"S Mohammed","year":"2023","unstructured":"Mohammed S, Bindu A, Viswanathan A, Harikumar KB (2023) Sphingosine 1-phosphate signaling during infection and immunity. Prog Lipid Res 92:101251. https:\/\/doi.org\/10.1016\/j.plipres.2023.101251","journal-title":"Prog Lipid Res"},{"issue":"12","key":"2206_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/v11121097","volume":"11","author":"JJ Wolf","year":"2019","unstructured":"Wolf JJ, Studstill CJ, Hahm B (2019) Emerging connections of S1P-metabolizing enzymes with host defense and immunity during virus infections. Viruses 11(12):1097. https:\/\/doi.org\/10.3390\/v11121097","journal-title":"Viruses"},{"key":"2206_CR41","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.virol.2021.02.006","volume":"558","author":"JJ Wolf","year":"2021","unstructured":"Wolf JJ et al (2021) Influenza A virus NS1 induces degradation of sphingosine 1-phosphate lyase to obstruct the host innate immune response. Virology 558:67\u201375. https:\/\/doi.org\/10.1016\/j.virol.2021.02.006","journal-title":"Virology"},{"issue":"11","key":"2206_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/v8110308","volume":"8","author":"Y Jiang","year":"2016","unstructured":"Jiang Y, Qin Y, Chen M (2016) Host\u2013pathogen interactions in measles virus replication and anti-viral immunity. Viruses 8(11):308. https:\/\/doi.org\/10.3390\/v8110308","journal-title":"Viruses"},{"issue":"4","key":"2206_CR43","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s11262-022-01902-y","volume":"58","author":"M Rastegarpanah","year":"2022","unstructured":"Rastegarpanah M, Azadmanesh K, Negahdari B, Asgari Y, Mazloomi M (2022) Screening of candidate genes associated with high titer production of oncolytic measles virus based on systems biology approach. Virus Genes 58(4):270\u2013283. https:\/\/doi.org\/10.1007\/s11262-022-01902-y","journal-title":"Virus Genes"}],"container-title":["Virus Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11262-025-02206-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11262-025-02206-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11262-025-02206-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T10:04:18Z","timestamp":1779357858000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11262-025-02206-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,6]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2206"],"URL":"https:\/\/doi.org\/10.1007\/s11262-025-02206-7","relation":{},"ISSN":["0920-8569","1572-994X"],"issn-type":[{"value":"0920-8569","type":"print"},{"value":"1572-994X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,6]]},"assertion":[{"value":"27 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study involving human cell lines were conducted in accordance with the ethical standards of the Medical Ethics Committee at the Tehran University of Medical Sciences (TUMS) and adhered to the principles outlined in the 1964 Helsinki Declaration, including its later amendments, or to comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and animal participants"}},{"value":"Human diploid lung fibroblast cell line MRC-5 (RRID: CVCL_RB14), adenocarcinomic human alveolar basal epithelial cells A549 (RRID: CVCL_VR66), human embryonic kidney 293 cells (RRID: CVCL_0045), immortal human\u00a0cell\u00a0line HeLa (RRID: CVCL_0030), and human hepatocyte carcinoma cell line HepG2 (RRID: CVCL_0027) were obtained from the \u201cAmerican Type Culture Collection (ATCC),\u201d and informed consent is not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}